Drug Shortage Report for TEVA-ESOMEPRAZOLE
Report ID | 104339 |
Drug Identification Number | 02423863 |
Brand name | TEVA-ESOMEPRAZOLE |
Common or Proper name | ESOMEPRAZOLE 40MG OG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 30UD |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-01-22 |
Estimated end date | 2021-03-31 |
Actual end date | 2021-03-10 |
Shortage status | Resolved |
Updated date | 2021-03-11 |
Company comments | Allocating until re-supply |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.